1. Home
  2. NEUE vs RANI Comparison

NEUE vs RANI Comparison

Compare NEUE & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUE
  • RANI
  • Stock Information
  • Founded
  • NEUE 2015
  • RANI 2012
  • Country
  • NEUE United States
  • RANI United States
  • Employees
  • NEUE N/A
  • RANI N/A
  • Industry
  • NEUE
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • NEUE
  • RANI Health Care
  • Exchange
  • NEUE NYSE
  • RANI Nasdaq
  • Market Cap
  • NEUE 60.7M
  • RANI 55.3M
  • IPO Year
  • NEUE 2021
  • RANI 2021
  • Fundamental
  • Price
  • NEUE $6.85
  • RANI $1.36
  • Analyst Decision
  • NEUE Hold
  • RANI Strong Buy
  • Analyst Count
  • NEUE 1
  • RANI 6
  • Target Price
  • NEUE $7.00
  • RANI $11.33
  • AVG Volume (30 Days)
  • NEUE 44.8K
  • RANI 157.3K
  • Earning Date
  • NEUE 03-20-2025
  • RANI 05-05-2025
  • Dividend Yield
  • NEUE N/A
  • RANI N/A
  • EPS Growth
  • NEUE N/A
  • RANI N/A
  • EPS
  • NEUE N/A
  • RANI N/A
  • Revenue
  • NEUE $936,657,000.00
  • RANI N/A
  • Revenue This Year
  • NEUE $13.81
  • RANI N/A
  • Revenue Next Year
  • NEUE $6.75
  • RANI N/A
  • P/E Ratio
  • NEUE N/A
  • RANI N/A
  • Revenue Growth
  • NEUE N/A
  • RANI N/A
  • 52 Week Low
  • NEUE $3.79
  • RANI $1.24
  • 52 Week High
  • NEUE $7.66
  • RANI $8.75
  • Technical
  • Relative Strength Index (RSI)
  • NEUE 55.68
  • RANI 40.48
  • Support Level
  • NEUE $4.30
  • RANI $1.30
  • Resistance Level
  • NEUE $6.99
  • RANI $1.56
  • Average True Range (ATR)
  • NEUE 0.64
  • RANI 0.09
  • MACD
  • NEUE 0.15
  • RANI -0.02
  • Stochastic Oscillator
  • NEUE 92.73
  • RANI 23.08

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

Share on Social Networks: